Narcolepsy
This disease is characterized by irresistible short-term sleep attacks. It is a syndrome with unclear etiology, characterized by abnormal sleep tendencies, including excessive daytime sleepiness, restless sleep at night, and pathological REM sleep. It often starts in childhood or adolescence, and the incidence rate is similar in men and women. Some patients may have a history of encephalitis or craniocerebral trauma. Its pathogenesis is not yet clear, and it may be related to the decreased function of the ascending activation system of the brainstem reticular formation or the hyperfunction of the caudal pons reticular nucleus. Most patients are accompanied by other symptoms such as cataplexy, sleep paralysis, and sleep hallucinations, collectively known as the narcolepsy tetrad.
Related Drugs
MODAFINIL- modafinil_tablet
Indication: Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use Modafinil tablets are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). () Limitations of Use.
Manufacturer:
Preferred Pharmaceuticals Inc.
METHYLPHENIDATE HYDROCHLORIDE- methylphenidate hydrochloride_tablet, extended release
Indication: Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of: Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults Narcolepsy Methylphenidate hydrochloride extended-release tablet is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy.
Manufacturer:
Golden State Medical Supply, Inc.
PROVIGIL- provigil_tablet, film coated
Indication: PROVIGIL is indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Limitations of Use In OSA, PROVIGIL is indicated to treat excessive sleepiness and not as treatment for the underlying obstruction. If continuous positive airway pressure (CPAP) is the treatment of choice for a patient, a maximal effort to treat with CPAP for an adequate period of time should be made prior to initiating and during treatment with PROVIGIL for excessive sleepiness. ( 1 Limitations of Use.
Manufacturer:
Apotex Corp